ランキング
価格
はじめての方へ
ログイン
無料体験
米国企業
Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc.
NVCT
時価総額
$1.1億
PER
マイリストに追加
マイリストに追加
サマリーテーブルに戻る
十億
百万
千
USD
年次
四半期
Download CSV
損益計算書
バランスシート
キャッシュフロー
2022年
12月31日
2023年
12月31日
Cash and cash equivalents
20
19
Other current assets
0
0
TOTAL CURRENT ASSETS
20
19
TOTAL ASSETS
20
19
TOTAL ASSETS
20
19
Accounts payables
3
3
Accounts payables
3
3
Payable offering costs
0
-
Accrued liabilities
0
0
Employee compensation and benefits
2
4
TOTAL CURRENT LIABILITIES
6
7
Payable offering costs
0
-
TOTAL LIABILITIES
6
7
Accrued liabilities
0
0
Employee compensation and benefits
2
4
Additional paid in capital
46
66
Accumulated deficit
-32
-54
Additional paid in capital
46
66
TOTAL SHAREHOLDERS' EQUITY
14
12
Accumulated deficit
-32
-54
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19
TOTAL SHAREHOLDERS' EQUITY
14
12
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19
TOTAL CURRENT LIABILITIES
6
7
TOTAL LIABILITIES
6
7
Additional paid in capital
46
66
Accumulated deficit
-32
-54
Additional paid in capital
46
66
TOTAL SHAREHOLDERS' EQUITY
14
12
Accumulated deficit
-32
-54
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19
TOTAL SHAREHOLDERS' EQUITY
14
12
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19
Cash and cash equivalents
20
19
Other current assets
0
0
TOTAL CURRENT ASSETS
20
19
TOTAL ASSETS
20
19
TOTAL ASSETS
20
19
Accounts payables
3
3
Accounts payables
3
3
Payable offering costs
0
-
Accrued liabilities
0
0
Employee compensation and benefits
2
4
TOTAL CURRENT LIABILITIES
6
7
Payable offering costs
0
-
TOTAL LIABILITIES
6
7
Accrued liabilities
0
0
Employee compensation and benefits
2
4
Additional paid in capital
46
66
Accumulated deficit
-32
-54
Additional paid in capital
46
66
TOTAL SHAREHOLDERS' EQUITY
14
12
Accumulated deficit
-32
-54
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19
TOTAL SHAREHOLDERS' EQUITY
14
12
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19
TOTAL CURRENT LIABILITIES
6
7
TOTAL LIABILITIES
6
7
Additional paid in capital
46
66
Accumulated deficit
-32
-54
Additional paid in capital
46
66
TOTAL SHAREHOLDERS' EQUITY
14
12
Accumulated deficit
-32
-54
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19
TOTAL SHAREHOLDERS' EQUITY
14
12
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19